230 related articles for article (PubMed ID: 27074165)
1. Promoting inflammatory lymphangiogenesis by vascular endothelial growth factor-C (VEGF-C) aggravated intestinal inflammation in mice with experimental acute colitis.
Wang XL; Zhao J; Qin L; Qiao M
Braz J Med Biol Res; 2016; 49(5):e4738. PubMed ID: 27074165
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Artemisinin on Inflammation-Associated Lymphangiogenesis in Experimental Acute Colitis.
Lee AS; Hur HJ; Sung MJ
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33138094
[TBL] [Abstract][Full Text] [Related]
3. VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis.
Scaldaferri F; Vetrano S; Sans M; Arena V; Straface G; Stigliano E; Repici A; Sturm A; Malesci A; Panes J; Yla-Herttuala S; Fiocchi C; Danese S
Gastroenterology; 2009 Feb; 136(2):585-95.e5. PubMed ID: 19013462
[TBL] [Abstract][Full Text] [Related]
4. COMP-angiopoietin-1 ameliorates inflammation-induced lymphangiogenesis in dextran sulfate sodium (DSS)-induced colitis model.
Lee AS; Sung MJ; Kim W; Jung YJ
J Mol Med (Berl); 2018 May; 96(5):459-467. PubMed ID: 29610929
[TBL] [Abstract][Full Text] [Related]
5. Platelet interaction with lymphatics aggravates intestinal inflammation by suppressing lymphangiogenesis.
Sato H; Higashiyama M; Hozumi H; Sato S; Furuhashi H; Takajo T; Maruta K; Yasutake Y; Narimatsu K; Yoshikawa K; Kurihara C; Okada Y; Watanabe C; Komoto S; Tomita K; Nagao S; Miura S; Hokari R
Am J Physiol Gastrointest Liver Physiol; 2016 Aug; 311(2):G276-85. PubMed ID: 27313177
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E receptor EP4 stimulates lymphangiogenesis to promote mucosal healing during DSS-induced colitis.
Hosono K; Kojo K; Narumiya S; Majima M; Ito Y
Biomed Pharmacother; 2020 Aug; 128():110264. PubMed ID: 32447215
[TBL] [Abstract][Full Text] [Related]
7. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
[TBL] [Abstract][Full Text] [Related]
8. VEGF-C/VEGFR-3 axis protects against pressure-overload induced cardiac dysfunction through regulation of lymphangiogenesis.
Lin QY; Zhang YL; Bai J; Liu JQ; Li HH
Clin Transl Med; 2021 Mar; 11(3):e374. PubMed ID: 33783987
[TBL] [Abstract][Full Text] [Related]
9. VEGF-C and VEGF-C156S in the pro-lymphangiogenic growth factor therapy of lymphedema: a large animal study.
Visuri MT; Honkonen KM; Hartiala P; Tervala TV; Halonen PJ; Junkkari H; Knuutinen N; Ylä-Herttuala S; Alitalo KK; Saarikko AM
Angiogenesis; 2015 Jul; 18(3):313-26. PubMed ID: 26018927
[TBL] [Abstract][Full Text] [Related]
10. Activation of the VEGFR-3 pathway by VEGF-C attenuates UVB-induced edema formation and skin inflammation by promoting lymphangiogenesis.
Kajiya K; Sawane M; Huggenberger R; Detmar M
J Invest Dermatol; 2009 May; 129(5):1292-8. PubMed ID: 19005491
[TBL] [Abstract][Full Text] [Related]
11. Combination of IL-24 and cisplatin inhibits angiogenesis and lymphangiogenesis of cervical cancer xenografts in a nude mouse model by inhibiting VEGF, VEGF-C and PDGF-B.
Wang Z; Lv J; Zhang T
Oncol Rep; 2015 May; 33(5):2468-76. PubMed ID: 25778843
[TBL] [Abstract][Full Text] [Related]
12. The VEGF-C/VEGFR3 signaling pathway contributes to resolving chronic skin inflammation by activating lymphatic vessel function.
Hagura A; Asai J; Maruyama K; Takenaka H; Kinoshita S; Katoh N
J Dermatol Sci; 2014 Feb; 73(2):135-41. PubMed ID: 24252749
[TBL] [Abstract][Full Text] [Related]
13. VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease.
D'Alessio S; Correale C; Tacconi C; Gandelli A; Pietrogrande G; Vetrano S; Genua M; Arena V; Spinelli A; Peyrin-Biroulet L; Fiocchi C; Danese S
J Clin Invest; 2014 Sep; 124(9):3863-78. PubMed ID: 25105363
[TBL] [Abstract][Full Text] [Related]
14. Mouse strain influences angiogenic response to dextran sodium sulfate-induced colitis.
Knod JL; Crawford K; Dusing M; Frischer JS
J Surg Res; 2014 Jul; 190(1):47-54. PubMed ID: 24793451
[TBL] [Abstract][Full Text] [Related]
15. Role of VEGF-C and VEGF-D in lymphangiogenesis in gastric cancer.
Yonemura Y; Endo Y; Tabata K; Kawamura T; Yun HY; Bandou E; Sasaki T; Miura M
Int J Clin Oncol; 2005 Oct; 10(5):318-27. PubMed ID: 16247658
[TBL] [Abstract][Full Text] [Related]
16. Transgenic induction of vascular endothelial growth factor-C is strongly angiogenic in mouse embryos but leads to persistent lymphatic hyperplasia in adult tissues.
Lohela M; Heloterä H; Haiko P; Dumont DJ; Alitalo K
Am J Pathol; 2008 Dec; 173(6):1891-901. PubMed ID: 18988807
[TBL] [Abstract][Full Text] [Related]
17. Lymphangiogenesis and angiogenesis in bladder cancer: prognostic implications and regulation by vascular endothelial growth factors-A, -C, and -D.
Miyata Y; Kanda S; Ohba K; Nomata K; Hayashida Y; Eguchi J; Hayashi T; Kanetake H
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):800-6. PubMed ID: 16467091
[TBL] [Abstract][Full Text] [Related]
18. Murine colitis treated with multitargeted tyrosine kinase inhibitors.
Knod JL; Crawford K; Dusing M; Frischer JS
J Surg Res; 2016 Feb; 200(2):501-7. PubMed ID: 26521099
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of FoxC2 Increased Susceptibility to Experimental Colitis: Influence of Lymphatic Drainage Function?
Becker F; Potepalov S; Shehzahdi R; Bernas M; Witte M; Abreo F; Traylor J; Orr WA; Tsunoda I; Alexander JS
Inflamm Bowel Dis; 2015 Jun; 21(6):1282-96. PubMed ID: 25822012
[TBL] [Abstract][Full Text] [Related]
20. VEGFR-3 blocking deteriorates inflammation with impaired lymphatic function and different changes in lymphatic vessels in acute and chronic colitis.
Wang XL; Zhao J; Qin L; Cao JL
Am J Transl Res; 2016; 8(2):827-41. PubMed ID: 27158372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
